Our results indicated that Gal-3 is required for TLR-4-dependent activation of IDO-1/KYN pathway in colon-infiltrating DCs and for consequent Tregs-based suppression of Th1/Th17 cell-driven colon inflammation. This evidence concerns the gene LGALS3 and digestive system neoplasm.